32436237|t|High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities.
32436237|a|BACKGROUND AND PURPOSE: Although diabetes mellitus (DM) is an important risk factor for Alzheimer's disease (AD), the detailed mechanism(s) by which DM regulates amyloid beta (Abeta) processing is still unclear. The longer residence time of amyloid precursor protein (APP) in endosomes is critical for Abeta production and DM is known to cause endosomal dysregulation. Here we have examined the effects of high glucose on APP-producing endosomes and related signaling pathways. EXPERIMENTAL APPROACH: To identify the underlying mechanisms, we investigated the effects of high glucose on abnormalities in early endosomes and related signalling pathways in human neuroblastoma cells. In vivo, diabetic mice treated with pharmacological inhibitors were used to examine endosomal dysfunction. KEY RESULTS: The hippocampus of diabetic animals presented endosomal abnormalities and Abeta up-regulation. High glucose increased Abeta production through early endosomal enlargement achieved by increased lipid raft-mediated APP endocytosis. High glucose induced ROS-stimulated Sp1 activation, up-regulating phosphatidylinositol binding clathrin assembly protein (PICALM), clathrin heavy chain, and adaptor-related protein complex 2 alpha 1. PICALM facilitated clathrin-mediated APP endocytosis resulting in early endosomal enlargement. Meanwhile, AMPK/mTORC1-mediated autophagy defect and ROS- and mTORC1-mediated lysosomal dysfunction aggravated early endosomal enlargement under high glucose. Moreover, the increased Abeta production and cognitive deficits in diabetic mice were reversed by inhibition of early endosomal enlargement. CONCLUSION AND IMPLICATIONS: High glucose induces early endosomal abnormalities through PICALM-induced APP endocytosis and mTORC1-inhibited endosomal clearance, up-regulating Abeta production. Thus, targeting PICALM and mTORC1 to prevent endosomal disorders is a promising strategy for managing diabetes-induced AD.
32436237	5	12	glucose	Chemical	MESH:D005947
32436237	22	28	PICALM	Gene	233489
32436237	63	88	amyloid precursor protein	Gene	11820
32436237	93	116	endosomal abnormalities	Disease	MESH:D000014
32436237	151	168	diabetes mellitus	Disease	MESH:D003920
32436237	170	172	DM	Disease	MESH:D003920
32436237	206	225	Alzheimer's disease	Disease	MESH:D000544
32436237	227	229	AD	Disease	MESH:D000544
32436237	267	269	DM	Disease	MESH:D003920
32436237	280	292	amyloid beta	Gene	351
32436237	294	299	Abeta	Gene	351
32436237	359	384	amyloid precursor protein	Gene	351
32436237	420	425	Abeta	Gene	351
32436237	441	443	DM	Disease	MESH:D003920
32436237	462	471	endosomal	Disease	
32436237	529	536	glucose	Chemical	MESH:D005947
32436237	694	701	glucose	Chemical	MESH:D005947
32436237	773	778	human	Species	9606
32436237	779	792	neuroblastoma	Disease	MESH:D009447
32436237	809	817	diabetic	Disease	MESH:D003920
32436237	818	822	mice	Species	10090
32436237	884	893	endosomal	Disease	
32436237	939	947	diabetic	Disease	MESH:D003920
32436237	966	989	endosomal abnormalities	Disease	MESH:D000014
32436237	994	999	Abeta	Gene	11820
32436237	1020	1027	glucose	Chemical	MESH:D005947
32436237	1038	1043	Abeta	Gene	351
32436237	1069	1078	endosomal	Disease	
32436237	1113	1118	lipid	Chemical	MESH:D008055
32436237	1155	1162	glucose	Chemical	MESH:D005947
32436237	1171	1174	ROS	Chemical	-
32436237	1216	1270	phosphatidylinositol binding clathrin assembly protein	Gene	8301
32436237	1272	1278	PICALM	Gene	8301
32436237	1281	1301	clathrin heavy chain	Gene	1213
32436237	1350	1356	PICALM	Gene	8301
32436237	1422	1431	endosomal	Disease	
32436237	1498	1501	ROS	Chemical	-
32436237	1523	1544	lysosomal dysfunction	Disease	MESH:D016464
32436237	1562	1571	endosomal	Disease	
32436237	1595	1602	glucose	Chemical	MESH:D005947
32436237	1628	1633	Abeta	Gene	11820
32436237	1649	1667	cognitive deficits	Disease	MESH:D003072
32436237	1671	1679	diabetic	Disease	MESH:D003920
32436237	1680	1684	mice	Species	10090
32436237	1722	1731	endosomal	Disease	
32436237	1779	1786	glucose	Chemical	MESH:D005947
32436237	1801	1824	endosomal abnormalities	Disease	MESH:D000014
32436237	1833	1839	PICALM	Gene	8301
32436237	1885	1894	endosomal	Disease	
32436237	1920	1925	Abeta	Gene	11820
32436237	1954	1960	PICALM	Gene	8301
32436237	1983	2002	endosomal disorders	Disease	MESH:D009358
32436237	2040	2048	diabetes	Disease	MESH:D003920
32436237	2057	2059	AD	Disease	MESH:D000544
32436237	Association	MESH:D005947	MESH:D016464
32436237	Positive_Correlation	MESH:D005947	1213
32436237	Association	MESH:D009358	8301
32436237	Association	MESH:D003920	8301
32436237	Positive_Correlation	MESH:D005947	351
32436237	Association	MESH:D000014	11820
32436237	Positive_Correlation	MESH:D005947	8301
32436237	Association	11820	233489
32436237	Positive_Correlation	MESH:D003920	11820
32436237	Positive_Correlation	MESH:D005947	11820
32436237	Association	MESH:D003920	351
32436237	Association	11820	8301
32436237	Association	MESH:D005947	233489
32436237	Positive_Correlation	MESH:D005947	MESH:D000014
32436237	Association	MESH:D000544	8301
32436237	Association	MESH:D000014	8301
32436237	Association	MESH:D000014	233489

